Details

Plodnost in reproduktivno zdravje po sistemskem zdravljenju raka testisov
ID Bodiroža, Strahinja (Author), ID Thaler, Darja (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (492,69 KB)
MD5: C421E6C5961A5F37AABC6654087E46D3

Abstract
Uvod: Rak testisov najpogosteje prizadene mlajše moške v reproduktivnem obdobju, zato lahko bolezen in njeno zdravljenje pomembno vplivata na možnosti prihodnjega očetovstva. Kljub uspešnemu zdravljenju se pri nekaterih pacientih pojavijo dolgotrajne težave s plodnostjo. Pomembno je pravočasno informiranje o možnih posledicah zdravljenja in možnostih ohranjanja plodnosti. Namen: Namen diplomskega dela je bil ugotoviti vpliv sistemskega zdravljenja raka testisov na plodnost in reproduktivno zdravje, predvsem na spermatogenezo in hormonsko ravnovesje. Želeli smo predstaviti možnosti ohranjanja plodnosti ter vlogo zdravstvenih delavcev pri informiranju, svetovanju in podpori pacientom. Metode dela: Uporabili smo deskriptivno metodo s pregledom znanstvene in strokovne literature. Literaturo smo iskali v podatkovnih bazah PubMed, ScienceDirect in SpringerLink ter spletnem iskalniku Google Učenjak med junijem in septembrom 2026. Uporabili smo angleške ključne besede in Boolova operatorja AND ter OR. Upoštevali smo članke, objavljene med letoma 2016 in 2026. V končno analizo smo vključili 12 raziskav, ki smo jih razvrstili glede na raven dokazov in vsebinsko analizirali. Rezultati: Sistemsko zdravljenje raka testisov lahko povzroči zmanjšanje koncentracije in gibljivosti spermijev ter motnje spermatogeneze, predvsem po kemoterapiji na osnovi cisplatina. Pri nekaterih pacientih se reproduktivna funkcija postopoma obnovi, vendar lahko okrevanje traja več let. Krioprezervacija semena lahko prispeva k ohranjanju možnosti poznejšega biološkega očetovstva tudi pri pacientih z zmanjšano kakovostjo semena. Pacienti se pri odločanju zanjo srečujejo s časovnimi, finančnimi in organizacijskimi ovirami. Razprava in zaključek: Posledice sistemskega zdravljenja za plodnost se med pacienti razlikujejo, kakovost semena pa je lahko zmanjšana že pred zdravljenjem. Čeprav je okrevanje spermatogeneze pogosto mogoče, njegovega poteka ni mogoče zanesljivo napovedati. Zato sta pomembna zgodnje svetovanje in pravočasna krioprezervacija semena, po potrebi že pred operativnim zdravljenjem. Medicinske sestre imajo pomembno vlogo pri prepoznavanju pacientovih potreb, preverjanju razumevanja informacij, podpori pri odločanju in interdisciplinarnem sodelovanju. Zaradi razlik med raziskavami in omejenih podatkov o hormonskih spremembah ter intervencijah zdravstvene nege so potrebne nadaljnje raziskave.

Language:Slovenian
Keywords:spermatogeneza, kemoterapija, krioprezervacija semena, očetovstvo, zdravstvena nega
Work type:Bachelor thesis/paper
Organization:ZF - Faculty of Health Sciences
Year:2026
PID:20.500.12556/RUL-190954 This link opens in a new window
Publication date in RUL:08.11.2026
Views:23
Downloads:2
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Secondary language

Language:Unknown
Title:Fertility and reproductive health after systemic treatment for testicular cancer
Abstract:
Introduction: Testicular cancer most commonly affects younger men of reproductive age, and both the disease and its treatment may significantly affect their chances of future fatherhood. Despite successful treatment, some patients experience long-term fertility problems. Timely information about the potential consequences of treatment and available fertility preservation options is therefore important. Purpose: The purpose of this diploma thesis was to examine the impact of systemic treatment for testicular cancer on fertility and reproductive health, particularly spermatogenesis and hormonal balance. We also aimed to present fertility preservation options and the role of healthcare professionals in providing information, counselling and support to patients. Methods: We used a descriptive method based on a review of scientific and professional literature. We searched the PubMed, ScienceDirect and SpringerLink databases and the Google Scholar search engine between June and September 2026. English search terms and the Boolean operators AND and OR were used. Articles published between 2016 and 2026 were considered. A total of 12 studies were included in the final analysis, classified according to their levels of evidence and analysed using content analysis. Results: Systemic treatment for testicular cancer may reduce sperm concentration and motility and impair spermatogenesis, particularly following cisplatin-based chemotherapy. In some patients, reproductive function gradually recovers, although recovery may take several years. Semen cryopreservation may help preserve the possibility of future biological fatherhood, even in patients with reduced semen quality. Patients also face time-related, financial and organisational barriers when deciding whether to undergo semen cryopreservation. Discussion and conclusion: The effects of systemic treatment on fertility vary among patients, and semen quality may already be reduced before treatment. Although spermatogenesis may recover in many patients, the course of recovery cannot be reliably predicted. Early counselling and timely semen cryopreservation, potentially even before surgical treatment, are therefore important. Nurses play an important role in identifying patients' needs, assessing their understanding of information, supporting decision-making and collaborating within an interdisciplinary team. Due to differences between the included studies and limited evidence on hormonal changes and nursing interventions, further research is needed.

Keywords:spermatogenesis, chemotherapy, sperm cryopreservation, fatherhood, nursing

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back